Canadian Cancer Trials Group Bulletins

General


San Antonio Breast Cancer Symposium

One abstract - related to Canadian Cancer Trials Group MA.22 -- Phase I/II Study of Increasing Doses of Epirubicin and Docetaxel Plus Pegfilgrastim for Locally Advanced or Inflammatory Breast Cancer -- is being presented at the 36th Annual San Antonio Breast Cancer Symposium being held December 10-14, 2013 in San Antonio, Texas.

For more information about this presentation, follow this link ... http://www.ctg.queensu.ca/public/publications/publications.html.